Evidence map›Paper›PMID 38413638›Full record

ArticleScientific reports2024

Bioprospecting of Artemisia genus: from artemisinin to other potentially bioactive compounds.

Stefano Negri, Fabio Pietrolucci, Sebastiano Andreatta, Ruth Chinyere Njoku, Carolina Antunes Silva Nogueira Ramos, Massimo Crimi, Mauro Commisso, Flavia Guzzo, Linda Avesani

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. A Systematic Review of Alternative Artemisinin Production Strategies.International journal of molecular sciences · 2025
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  6. Article
  7. KoreanFrontiers in pharmacology · 2026
    Review
  8. Article
  9. Effectiveness of Natural Products-Plants (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Genomic and phenotypic profiling of anFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Stefano Negri *Department of Biotechnology, University of Verona, 15, Strada Le Grazie, 37134, Verona, Italy.
Fabio Pietrolucci *Department of Biotechnology, University of Verona, 15, Strada Le Grazie, 37134, Verona, Italy.
Sebastiano AndreattaMuseo di Storia Naturale, Comune di Verona, 37126, Verona, Italy.
Ruth Chinyere NjokuDepartment of Biotechnology, University of Verona, 15, Strada Le Grazie, 37134, Verona, Italy.
Carolina Antunes Silva Nogueira RamosDepartment of Biotechnology, University of Verona, 15, Strada Le Grazie, 37134, Verona, Italy.
Massimo CrimiDepartment of Biotechnology, University of Verona, 15, Strada Le Grazie, 37134, Verona, Italy.
Mauro CommissoDepartment of Biotechnology, University of Verona, 15, Strada Le Grazie, 37134, Verona, Italy.
Flavia GuzzoDepartment of Biotechnology, University of Verona, 15, Strada Le Grazie, 37134, Verona, Italy. flavia.guzzo@univr.it.
Linda AvesaniDepartment of Biotechnology, University of Verona, 15, Strada Le Grazie, 37134, Verona, Italy. linda.avesani@univr.it.
University of Verona · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Species from genus Artemisia are widely distributed throughout temperate regions of the northern hemisphere and many cultures have a long-standing traditional use of these plants as herbal remedies, liquors, cosmetics, spices, etc. Nowadays, the discovery of new plant-derived products to be used as food supplements or drugs has been pushed by the exploitation of bioprospection approaches. Often driven by the knowledge derived from the ethnobotanical use of plants, bioprospection explores the existing biodiversity through integration of modern omics techniques with targeted bioactivity assays. In this work we set up a bioprospection plan to investigate the phytochemical diversity and the potential bioactivity of five Artemisia species with recognized ethnobotanical tradition (A. absinthium, A. alba, A. annua, A. verlotiorum and A. vulgaris), growing wild in the natural areas of the Verona province. We characterized the specialized metabolomes of the species (including sesquiterpenoids from the artemisinin biosynthesis pathway) through an LC-MS based untargeted approach and, in order to identify potential bioactive metabolites, we correlated their composition with the in vitro antioxidant activity. We propose as potential bioactive compounds several isomers of caffeoyl and feruloyl quinic acid esters (e.g. dicaffeoylquinic acids, feruloylquinic acids and caffeoylferuloylquinic acids), which strongly characterize the most antioxidant species A. verlotiorum and A. annua. Morevoer, in this study we report for the first time the occurrence of sesquiterpenoids from the artemisinin biosynthesis pathway in the species A. alba.

Indexed as

ArtemisiaArtemisininsSesquiterpenesBioprospectingartemisininArtemisininsSesquiterpenesAntioxidantsArtemisia spp.ArtemisininBioprospectionDicaffeoylquinic acidsSesquiterpenes

Identifiers

PMID38413638
PMCPMC10899597
OpenAlexW4392201000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.